News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
CeNeS Pharmaceuticals PLC Chairman Buys 500,000 Shares, CEO Buys 120,000 At 8p Each
December 16, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CeNeS Pharmaceuticals PLC said chairman Alan Goodman bought 500,000 shares in the company at 8 pence each yesterday, while chief executive Neil Clark bought 120,000 shares at the same price.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Huntington’s disease
UniQure eyes UK approval for embattled Huntington’s gene therapy after FDA quarrel
April 30, 2026
·
2 min read
·
Heather McKenzie
Company closure
6 biotechs that called it quits in Q1
April 30, 2026
·
6 min read
·
Angela Gabriel
Regulatory
Amid US ordeal, Moderna wins EU approval for flu/COVID-19 combo shot
April 22, 2026
·
2 min read
·
Tristan Manalac
Insights
Funding the future of European biotech
April 16, 2026
·
1 min read
·
Jennifer C. Smith-Parker